Last updated: April 2, 2024
Sponsor: Ohio State University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hidradenitis Suppurativa
Rosacea
Acne Inversa
Treatment
N/AClinical Study ID
NCT03146676
2010H0331
All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Seen by an Ohio State University (OSU) Dermatology provider on the main UniversityHospital campus, including the James Cancer Hospital, OSU Dermatology East, OSUDermatology at the Ohio State Eye and Ear Institute, Martha Morehouse MedicalPavilion, and OSU Dermatology at Upper Arlington after the date of approval of thisprotocol
- Ability to provide informed consent, or parent or legal guardian capable of providingconsent for child or mentally handicapped individuals
- Willingness to participate in a research study.
Exclusion
Exclusion Criteria:
- Inability to provide informed consent
Study Design
Total Participants: 175
Study Start date:
April 19, 2017
Estimated Completion Date:
December 31, 2030
Study Description
Connect with a study center
OSU Dermatology West
Columbus, Ohio 43215
United StatesActive - Recruiting
OSU Dermatology East
Gahanna, Ohio 43230
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.